138 related articles for article (PubMed ID: 6314727)
1. Influence of antiganglioside antibodies on thyrotrophin binding and adenyl cyclase activity of thyroid plasma membranes.
Gardas A; Adler G; Lewartowska A; Faryna M; Nauman J
Acta Endocrinol (Copenh); 1983 Nov; 104(3):333-9. PubMed ID: 6314727
[TBL] [Abstract][Full Text] [Related]
2. Presence of gangliosides in the structure of membrane receptor for thyrotrophin.
Gardas A; Nauman J
Acta Endocrinol (Copenh); 1981 Dec; 98(4):549-55. PubMed ID: 6272516
[TBL] [Abstract][Full Text] [Related]
3. Modification of the adenylate cyclase activity of bovine thyroid plasma membranes by manipulating the ganglioside composition with a nonspecific lipid transfer protein.
Depauw H; De Wolf M; Van Dessel G; Lagrou A; Hilderson HJ; Dierick W
Biochim Biophys Acta; 1990 May; 1024(1):41-8. PubMed ID: 2337619
[TBL] [Abstract][Full Text] [Related]
4. Separation and analysis of two plasma membrane fractions from bovine thyroid which differ in TSH binding and TSH activation of adenylate cyclase.
Champier J; Munari-Silem Y; Alquier C; Audebet C; Rousset B
Mol Cell Endocrinol; 1985 Nov; 43(1):83-93. PubMed ID: 2998909
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin binding to and adenylate cyclase activity of porcine thyroid plasma membranes.
Verrier B; Planells R; Lissitzky S
Eur J Biochem; 1977 Apr; 74(2):243-52. PubMed ID: 192550
[TBL] [Abstract][Full Text] [Related]
6. Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes.
Mullin BR; Aloj SM; Fishman PH; Lee G; Kohn LD; Brady RO
Proc Natl Acad Sci U S A; 1976 May; 73(5):1679-83. PubMed ID: 179095
[TBL] [Abstract][Full Text] [Related]
7. Activation of adrenal adenyl cyclase by anti-thyroid plasma membrane antibodies.
Ong M; Malkin DG; Malkin A
Acta Endocrinol (Copenh); 1985 Oct; 110(2):244-50. PubMed ID: 2998133
[TBL] [Abstract][Full Text] [Related]
8. Characterization of regulation of thyrotropin (TSH) receptor function in thyroid plasma membrane: interaction between TSH receptor function and activation of adenosine 3',5'-monophosphate-dependent protein kinase.
Hashizume K; Yamauchi K; Miyamoto T; Ichikawa K; Kobayashi M
Endocrinol Jpn; 1986 Feb; 33(1):81-8. PubMed ID: 3013601
[TBL] [Abstract][Full Text] [Related]
9. The interaction of radioiodinated thyrotropin with human plasma membranes from normal and diseased thyroid glands. Relation of thyrotropin binding to adenylate cyclase activity.
Carayon P; Guibout M; Lissitzky S
Ann Endocrinol (Paris); 1979; 40(3):211-27. PubMed ID: 224798
[TBL] [Abstract][Full Text] [Related]
10. Adenyl cyclase activity in human thyroid plasma membranes from normal human thyroid tissue and thyroid adenomas.
Wålinder O; Karlsson FA; Dahlberg PA
Acta Endocrinol (Copenh); 1979 Sep; 92(1):95-104. PubMed ID: 227209
[TBL] [Abstract][Full Text] [Related]
11. Structure of the thyrotropin receptor and thyroid adenylate cyclase system as determined by target analysis.
Nielsen TB; Totsuka Y; Kempner ES; Field JB
Biochemistry; 1984 Dec; 23(25):6009-16. PubMed ID: 6098307
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
Yamashita K; Field JB
J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
[TBL] [Abstract][Full Text] [Related]
13. Relationship of gangliosides to the structure and function of thyrotropin receptors: their absence on plasma membranes of a thyroid tumor defective in thyrotropin receptor activity.
Fishman PH; Aloj SM; Kohn LD; Brady RO
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4060-4. PubMed ID: 186783
[TBL] [Abstract][Full Text] [Related]
14. Effect of various drugs on the binding of thyrotrophin to thyroid plasma membranes.
Baba Y; Nakao Y; Kishihara M; Kobayashi N; Kimoto H; Matsukura S; Fujita T; Kuma K
Acta Endocrinol (Copenh); 1982 Aug; 100(4):519-26. PubMed ID: 6181637
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-binding properties of isolated thyroid cells and their purified plasma membranes. Relation of thyrotropin-specific binding to adenylate-cyclase activation.
Verrier B; Fayet G; Lissitzky S
Eur J Biochem; 1974 Mar; 42(2):355-65. PubMed ID: 4364247
[No Abstract] [Full Text] [Related]
16. Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system.
Amr S; Menezez-Ferreira M; Shimohigashi Y; Chen HC; Nisula B; Weintraub BD
J Endocrinol Invest; 1985 Dec; 8(6):537-41. PubMed ID: 3009595
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.
Valente WA; Yavin Z; Yavin E; Grollman EF; Schneider M; Rotella CM; Zonefrati R; Toccafondi RS; Kohn LD
J Endocrinol Invest; 1982; 5(5):293-301. PubMed ID: 6296219
[TBL] [Abstract][Full Text] [Related]
18. The binding of thyrotropin to isolated bovine thyroid plasma membranes.
Amir SM; Carraway TF; Kohn LD; Winand RJ
J Biol Chem; 1973 Jun; 248(11):4092-100. PubMed ID: 4122527
[No Abstract] [Full Text] [Related]
19. Abnormal adenylate cyclase activity and altered membrane gangliosides in thyroid cells from patients with Graves' disease.
Lee G; Grollman EF; Aloj SM; Kohn LD; Winand RJ
Biochem Biophys Res Commun; 1977 Jul; 77(1):139-46. PubMed ID: 578114
[No Abstract] [Full Text] [Related]
20. Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease.
Lacetti P; Tombaccini D; Aloj S; Grollman EF; Kohn LD
Adv Exp Med Biol; 1984; 174():355-67. PubMed ID: 6331133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
